NCT01577355View on ClinicalTrials.gov

A Study of LY2784544 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Healthy Male Volunteers
Interventions
RADIATION

Drug

Single 30 mg oral dose containing 100 micro curies of LY2784544

Trial Locations (1)

53704

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01577355 - A Study of LY2784544 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter